Reporter loses battle with blood cancer aged 50 holdthefrontpage.co.uk Thu, 29 Jul 2010 21:58 PM PDT A 'courageous' reporter at a weekly paper who fought blood cancer for more than a year has died at the age of 50. Charlotte Taylor, left, had worked for the Mid Sussex Times since 2003 but lost her battle with the disease last Friday at St Wilfrid's Hospice in Eastbourne. | Allos gets positive results from phase-2b study of Folotyn in patients with advanced NSCLC PharmaBiz Thu, 29 Jul 2010 21:42 PM PDT Allos Therapeutics, Inc announced topline results from the company's randomized phase-2b investigational trial of Folotyn (pralatrexate injection) versus erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC) who had received one or two prior systemic treatments including at least one prior platinum-based regimen. | Incompetent care led to Dingle's death Australian Broadcasting Corporation Thu, 29 Jul 2010 21:41 PM PDT WA's State Coroner has found misinformation and poor science led to a woman's death from cancer after she decided to treat her disease with homeopathy instead of conventional medicine. | Stephanie Lynn Good Estes Park Trail Gazette Thu, 29 Jul 2010 21:41 PM PDT Stephanie Lynn Good, 31, died June 9, 2010, in Marietta, Ga. after a courageous fight against cancer. | Test designed to screen resistance to cancer drug AlertNet Thu, 29 Jul 2010 21:33 PM PDT Source: Reuters (Corrects spelling of brand name in paragraph 4) HONG KONG, July 29 (Reuters) - Researchers in Japan have designed a test to identify patients who are likely to be resistant to imatinib, the ... | Province approves funding for another kidney cancer drug Kitchener - Waterloo Record Thu, 29 Jul 2010 21:31 PM PDT Another life-extending drug for kidney cancer patients was recently approved for provincial funding, but advocates say there are still far too many limitations to drug therapy in Ontario and across Canada. | Bayer Corp. revenue, sales rise but net income falls Pittsburgh Post-Gazette Thu, 29 Jul 2010 21:24 PM PDT Strong demand for its plastics and chemical materials boosted revenue growth at Bayer Corp. by 15 percent in the second quarter, but net income slipped by 1.3 percent because of one-time legal charges and the cost of a write-down on a cancer drug. The German-based chemicals and pharmaceuticals maker said sales shot up by nearly 15 percent to $12 billion. | Dragons vs. cancer The Fort Dodge Messenger Thu, 29 Jul 2010 21:23 PM PDT Boats won't race today, but crowds are expected at the opening ceremony of the 14th annual Dragon Boat Bash at Badger Lake in John F. Kennedy Memorial Park. | | |
|
No comments:
Post a Comment